Clinical implications of free-to-total immunoreactive prostate-specific antigen ratios.

Autor: Wymenga, L. F. A.¹, Duisterwinkel, F. J., Groenier, K., Brummen, P. Visser-van, Marrink, J., Mensink, H. J. A.

Publikováno v: Scandinavian Journal of Urology & Nephrology. Aug2000, Vol. 34 Issue 3, p181-187. 7p.

Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis

Autor: Wymenga, L. F., Groenier, K., Schuurman, J., Boomsma, J. H., Elferink, R. O., Mensink, H. J.

Publikováno v: BJU International, 88, 231--5
BJU International, 88, 3, pp. 231--5
BJU international, 88(3), 231-235. Wiley-Blackwell

Item does not contain fulltext OBJECTIVE: To assess the predictive role of the bone markers alkaline phosphatase (ALP) and urinary deoxypyridinoline (DPD), as indicators of bone turnover, at baseline in patients with prostate cancer. PATIENTS, SUBJEC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eb0b962e9d993dcfe147c1d16773025b
https://hdl.handle.net/2066/186887

Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.

Autor: van Doeveren T; Erasmus University Medical Center, Rotterdam, The Netherlands., van Leeuwen PJ; Erasmus University Medical Center, Rotterdam, The Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organisation, The Netherlands.; Radboud University Medical Center, Nijmegen, The Netherlands., van der Aa M; Spaarne Medical Center, Hoofddorp, The Netherlands., Barendrecht M; Tergooi Medical Center, Hilversum, The Netherlands., Boevé ER; Fransiscus Medical Center, Rotterdam, The Netherlands., Cornel EB; Ziekenhuis Groep Twente, Almelo and Hengelo, The Netherlands., van der Heijden AG; Radboud University Medical Center, Nijmegen, The Netherlands., Hendricksen K; Netherlands Cancer Institute, Amsterdam, The Netherlands., Hirdes W; Isala Medical Center, Zwolle, The Netherlands., Kooistra A; Meander Medical Center, Amersfoort, The Netherlands., Kroon B; Rijnstate Medical Center, Arnhem, The Netherlands., Leliveld AM; University Medical Center Groningen, Groningen, The Netherlands., Meijer RP; University Medical Center Utrecht, Utrecht, The Netherlands., van Melick H; Sint Antonius Medical Center, Nieuwegein, The Netherlands., Merks B; Haaglanden Medical Center, Leidschendam, The Netherlands., de Reijke TM; Academic Medical Center, Amsterdam, The Netherlands., de Vries P; Zuyderland Medical Center, Heerlen, The Netherlands., Wymenga LFA; Martini Medical Center, Groningen, The Netherlands., Wijsman B; Elisabeth-TweeSteden Medical Center, Tilburg, The Netherlands., Boormans JL; Erasmus University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Contemporary clinical trials communications [Contemp Clin Trials Commun] 2018 Feb 28; Vol. 9, pp. 121-129. Date of Electronic Publication: 2018 Feb 28 (Print Publication: 2018).